Table 1

Characteristics of Women With a Diagnosis of Breast Cancer (N=105,105)

CharacteristicValue
Total ambulatory primary care physician visits, n (%)
 0–121,469 (20.4)
 2–419,355 (18.4)
 5–1033,364 (31.7)
 ≥1130,917 (29.4)
Total ambulatory non–primary care physician visits, n (%)
 0–139,031 (37.1)
 2–423,308 (22.2)
 5–1023,230 (22.1)
  ≥1119,536 (18.6)
Age at diagnosis, y (%)
 67–7551,290 (48.8)
 76–8542,913 (40.83)
  ≥8610,902 (10.37)
Race/ethnicity, n (%)
 White, non-Hispanic90,372 (86.0)
 Black, non-Hispanic6,694 (6.4)
 Hispanic3,931 (3.7)
 Asian/American Indian/Pacific Islander3,425 (3.3)
 Other683 (0.7)
Marital status, n (%)
 Single (never married)7,564 (7.2)
 Married43,030 (40.9)
 Separated/divorced6,913 (6.6)
 Widowed43,280 (41.2)
 Unknown4,318 (4.1)
MSA of residence, n (%)
 Large metropolitan60,122 (57.2)
 Metropolitan29,272 (27.9)
 Urban6,360 (6.1)
 Less urban7,632 (7.3)
 Rural1,714 (1.6)
Year of diagnosis, n (%)
 1994–199724,139 (23.0)
 1998–200023,597 (22.5)
 2001–200557,369 (54.6)
Histologic type, n (%)
 Ductal74,760 (71.1)
 Lobular17,176 (16.3)
 Ductal/lobular347 (0.3)
 Favorable5,961 (5.7)
 Unfavorable1,315 (1.3)
 Undefined5,546 (5.3)
Estrogen receptors, n (%)
 Positive/borderline49,010 (46.6)
 Negative9,147 (8.7)
 Missing46,948 (44.7)
Progesterone receptor, n (%)
 Positive/borderline40,265 (38.3)
 Negative17,027 (16.2)
 Missing47,813 (45.5
Tumor size, mm
 Mean (SD)20.2 (20.6)
 Median (minimum-maximum)15 (0–990)
AJCC stage at diagnosis, n (%)
 0 (in situ)14,568 (13.9)
 I42,830 (40.8)
 II27,602 (26.3)
 III6,012 (5.7)
 IV3,399 (3.2)
 Unknown10,694 (10.2)
Charlson comorbidity index, n (%)a
 061,466 (58.5)
 124,979 (23.8)
  ≥218,660 (17.8)
Influenza vaccination, n (%)
 No46,673 (44.4)
 Yes58,432 (55.6)
  • AJCC = American Joint Commission on Cancer; MSA = metropolitan statistical area.

  • a Scored on a range from 3–35, where higher scores indicate increased morbidity.